Page last updated: 2024-11-05

ethylene sulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9865
CHEMBL ID3184935
CHEBI ID30977
MeSH IDM0061330

Synonyms (48)

Synonym
ethylene episulfide
wln: t3stj
thiirene,3-dihydro-
sulfurane
nsc89690
aethylensulfid
nsc-89690
ccris 782
thiirene, 2,3-dihydro-
nsc 89690
thiiran
ai3-52351
epithioethane
ethylene episulphide
einecs 206-993-9
aethylensulfid [german]
hsdb 5489
thiacyclopropane
ethylene sulphide
2,3-dihydrothiirene
CHEBI:30977 ,
thiirane
420-12-2
inchi=1/c2h4s/c1-2-3-1/h1-2h
ethylene sulfide
ethylene sulfide, 98%
E0133
dimethylene sulfide
unii-a2w5165740
a2w5165740 ,
C19419
dtxsid3049411 ,
dtxcid2029371
tox21_202917
NCGC00260463-01
cas-420-12-2
ethylene sulfide [iarc]
ethylene sulfide [hsdb]
ethylene sulfide [mi]
ethylenesulfide
CHEMBL3184935
mfcd00005159
ethylene sulfide, purum, >=97.5% (gc)
ethylene sulfide (stabilised with butyl mercaptan)
Q220676
D90441
ethylene sulfide stabilized with ~1% butylmercaptan
AKOS037795694
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
saturated organic heteromonocyclic parent
organosulfur heterocyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency19.82370.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency7.96240.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.92)18.7374
1990's1 (1.96)18.2507
2000's18 (35.29)29.6817
2010's21 (41.18)24.3611
2020's9 (17.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.31 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index6.00 (4.65)
Search Engine Demand Index45.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (96.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]